Clinical Trials Logo

Cancer, Breast clinical trials

View clinical trials related to Cancer, Breast.

Filter by:

NCT ID: NCT04726319 Active, not recruiting - Clinical trials for Coronary Artery Disease

Family History App in Personalized Medicine

FHAMe
Start date: September 20, 2021
Phase: N/A
Study type: Interventional

A complete family history (FH) may identify persons at high risk for certain conditions. They can be offered genetic testing and life-saving screening and treatment. In practice, complete FH is rarely collected or entered into the electronic medical record (EMR). The Family History Screening Questionnaire is a survey patients complete to tell whether they are at increased risk of specific cancers, heart disease or diabetes. We will test a new way to record FH that includes an app to improve use of FH by family physicians and patients. The strategy includes education for patients and physicians about the importance of FH; patient completion of the FH questionnaire prior to appointments; and prompts in the EMR. We expect this to help family physicians and patients interpret FH and make the best decisions. We will assess the proportion of patients with new EMR FH information. We will explore if the strategy increases appropriate referrals for screening and genetic consultation for those at increased FH risk. We will also obtain patients' and physicians' feedback on this strategy. This new approach may improve FH information exchange between patients and physicians, encourage shared decision-making and reduce cancer deaths and chronic disease burden.

NCT ID: NCT04692168 Completed - Cancer, Breast Clinical Trials

Influence of Chemotherapy on Postural Control in Women With Cancer

Start date: October 7, 2020
Phase:
Study type: Observational

The aim of this study is to understand the strategies for adapting postural control in patients who have received chemotherapy treatment for gynaecological cancer.

NCT ID: NCT04608357 Recruiting - Breast Cancer Clinical Trials

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

Start date: July 21, 2021
Phase:
Study type: Observational [Patient Registry]

The investigators propose to use clinically validated patient avatar technology ("PDXovo") that can test multiple drugs against patients' cancers to identify the most promising systemic therapy for each individual.

NCT ID: NCT04554823 Active, not recruiting - Cancer, Breast Clinical Trials

Effects of a Physical Exercise and Health Education Program for Women With Breast Cancer Undergoing Chemotherapy

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to verify the effect of the intervention of a program of physical exercises and health education in women with breast cancer undergoing chemotherapy.

NCT ID: NCT04429893 Recruiting - Clinical trials for Chronic Pain Syndrome

Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy

Start date: January 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

Modified radical mastectomy may be associated with severe post-operative pain, leading to chronic pain syndrome which usually requires optimal perioperative pain management.

NCT ID: NCT04416087 Recruiting - Cancer, Breast Clinical Trials

Exercise and Tumor Blood Flow in Breast Cancer Patients

EXETUMOR2
Start date: September 7, 2020
Phase: N/A
Study type: Interventional

This research aims at investigating tumor blood flow response to acute exercise in human cancer patients. It is hypothesized and expected that acute exercise increases tumor blood flow, which could plausibly increase the efficacy of cancer treatment.

NCT ID: NCT04352530 Completed - Obesity Clinical Trials

Culturally Appropriate Nutrition Communication for Mexican American Women

Start date: March 25, 2019
Phase: N/A
Study type: Interventional

A randomized controlled trial to test the effects of culturally appropriate nutrition communication for Mexican American women.

NCT ID: NCT04326660 Completed - Obesity, Abdominal Clinical Trials

SCOPE-Chinese Women Study

SCOPE
Start date: July 20, 2020
Phase: N/A
Study type: Interventional

This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese women in China. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical activity. The intervention will be tailored to the participants' behaviors, personal needs, and preferences. The aim is to reduce abdominal obesity and improve healthy lifestyle behaviors in premenopausal women with children in order to reduce the growing cancer burden in China.

NCT ID: NCT04259762 Active, not recruiting - Cancer, Breast Clinical Trials

Enhancing Cancer Prevention and Control Pathways-Native Health Initiative

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

There are continued disparities in cancer incidence, mortality, and survival between American Indians (AIs) and Whites on cancers responsive to early screening (i.e., breast, colorectal, and cervical) in the US. In New Mexico (NM), AIs compared with other racial/ethnic populations are significantly less likely to adhere to recommended screening guidelines. The purpose of this trial is to develop and pilot test multilevel/multicomponent intervention strategies to enhance screening for breast, colorectal, and cervical cancers.

NCT ID: NCT04258813 Recruiting - Hypertension Clinical Trials

Onco-primary Care Networking to Support TEAM-based Care

ONE TEAM
Start date: June 14, 2021
Phase: N/A
Study type: Interventional

The proposed ONE TEAM Study is an 18-month, cluster randomized controlled trial. This study will use a sequential multiple assignment randomized trial (SMART) design with a second randomization for the intervention group using a dynamic treatment regimen approach. The investigators propose to randomize 800 adults with newly-diagnosed selected cancers treated with curative intent (breast, prostate, colorectal, endometrial, non-small cell lung, and endometrial) and with >1 selected cardiovascular disease (CVD) comorbidity (hypertension, type 2 diabetes mellitus, hypercholesterolemia). Participants will be enrolled through Duke Cancer Institute and two community-based oncology practices, both settings serving socio-demographically diverse populations. The unit of randomization will be the PCP clinic; there will be ~80 PCP clinics across North Carolina involved in the study. The overarching goals of this study are to improve chronic disease management and communication among cancer survivors by engaging PCPs as active members of the cancer care team and reframing the message to cancer survivors and providers. A diversity supplement with retrospective and qualitative components has been added to abstract older adults with solid tumors who underwent cancer surgery at DUHS. Aims include (1) to estimate the prevalence of cardiovascular complications ≤90 postoperative days among older adults with solid tumors undergoing surgery, and its association with care coordination between surgical providers and PCPs ; (2) to develop a risk index for cardiovascular complications ≤90 days of surgery among older adult patients with a solid tumor; and (3) to Assess experience and perceptions of PCPs on care coordination with surgical providers of older adults with a solid tumor following cancer surgery.